Neuraxis Inc (NRXS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Neuraxis Inc Stock (NRXS) Company Profile

Neuraxis Inc

Healthcare (1195)

Biotechnology (683)

(812) 689-0791

11550 North Meridian Street, Suite 325, Carmel

Prossima data di guadagno

Ultimi documenti SEC

NRXS's Discussions on Twitter

Confronta NRXS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NRXS	3.15	22.96M	0	0	0	-0.8066
VRTX	446.08	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	740.77	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.60	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.12	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.86	24.49B	3.30B	-501.07M	1.03B	11.54

Neuraxis Inc Borsa (NRXS) Ultime notizie

Neuraxis Inc Azioni (NRXS) Dati Finanziari

Non sono disponibili dati finanziari per Neuraxis Inc (NRXS). Controlla altri titoli per ulteriori informazioni.

Neuraxis Inc (NRXS)

Neuraxis Inc Stock (NRXS) Company Profile

Confronta NRXS con altri titoli

Neuraxis Inc Borsa (NRXS) Ultime notizie

Critical Review: BioSig Technologies (NASDAQ:BSGM) vs. NeurAxis (NASDAQ:NRXS) - Defense World

NeurAxis, Inc. (NASDAQ:NRXS) Q3 2024 Earnings Call Transcript - MSN

Neuraxis secures $5 million in preferred stock sale By Investing.com - Investing.com Canada

Neuronetics Grants Inducement Awards to New Employees - MSN

NeurAxis Stock Surges After Strong Q3 Earnings And Expanded Coverage - Barchart

NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage - Yahoo Finance

NeurAxis reports 40% increase in revenues in Q3 2024 - Medical Buyer

NeurAxis Reports Strong Revenue Growth in Q3 2024 - TipRanks

Neuraxis Inc. (NRXS) Quarterly 10-Q Report - Quartzy

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues - GlobeNewswire

NeurAxis Q3 Revenue Surges 40%, Expands Coverage to 35M Lives Amid FDA Milestone | NRXS Stock News - StockTitan

NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market - Building Indiana

NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024 - GlobeNewswire

NeurAxis (NRXS) Sets Q3 2024 Earnings Call for November 12 | Neuromodulation Leader | NRXS Stock News - StockTitan

IRIDEX (NASDAQ:IRIX) versus NeurAxis (NASDAQ:NRXS) Financial Survey - Defense World

NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 - The Manila Times

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewswire

Neuraxis adjusts equity agreement, secures additional funding - Investing.com India

Creatd (NASDAQ:VOCL) Stock Price Down 4.4% – Should You Sell? - Defense World

Technip Energies (OTCMKTS:THNPY) Trading Up 0.7% – Here’s What Happened - Defense World

Vestas Wind Systems A/S (OTCMKTS:VWSYF) Shares Up 1.2% – Here’s What Happened - Defense World

Zacks Initiates Coverage of NeurAxis With Neutral Recommendation - Yahoo Finance

The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis - Yahoo Finance

Top Analyst Reports for Costco Wholesale, Alibaba & GE Aerospace - Yahoo Finance

NeurAxis (NASDAQ:NRXS) Trading Up 6% - Defense World

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewswire

Neuraxis issues shares in equity financing By Investing.com - Investing.com Australia

Neuraxis issues shares in equity financing - Investing.com

Fishers startup prepares to go public - Greenfield Daily Reporter

NeurAxis (NASDAQ:NRXS) Stock Price Down 2.2% - Defense World

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - GlobeNewswire

Vagus Nerve Stimulators Market Projected to Witness Huge Growth - openPR

Neuraxis shareholders approve key proposals at annual meeting - Investing.com

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - GlobeNewswire

NeurAxis revenue down 5.3% to USD 611.5K in Q2 2024 - Medical Buyer

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript - Seeking Alpha

Contrasting Sonova (OTCMKTS:SONVY) & NeurAxis (NASDAQ:NRXS) - Defense World

NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024 - MSN

NeurAxis Reports Second Quarter 2024 Financial Results - GlobeNewswire

NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Vagus Nerve Stimulators Market Is Booming Worldwide 2024-2031 | - openPR

NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024 - GlobeNewswire

Neuraxis Inc Azioni (NRXS) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a NRXS